Added by | standudu |
---|---|
Group name | EquipeCTCS |
Item Type | Journal Article |
Title | Clinicopathological Correlates of ?? T Cell Infiltration in Triple-Negative Breast Cancer |
Creator | Boissière-Michot et al. |
Author | Florence Boissière-Michot |
Author | Ghita Chabab |
Author | Caroline Mollevi |
Author | Séverine Guiu |
Author | Evelyne Lopez-Crapez |
Author | Jeanne Ramos |
Author | Nathalie Bonnefoy |
Author | Virginie Lafont |
Author | William Jacot |
Abstract | The prognostic impact of the different tumor-infiltrating lymphocyte (TIL) subpopulations in solid cancers is still debated. Here, we investigated the clinicopathological correlates and prognostic impact of TILs, particularly of ?? T cells, in 162 patients with triple-negative breast cancer (TNBC). A high ?? T cell density (>6.625 ?? T cells/mm2) was associated with younger age (p = 0.008), higher tumor histological grade (p = 0.002), adjuvant chemotherapy (p = 0.010), BRCA1 promoter methylation (p = 0.010), TIL density (p < 0.001), and PD-L1 (p < 0.001) and PD-1 expression (p = 0.040). In multivariate analyses, ?? T cell infiltration (cutoff = 6.625 ?? T cells/mm2) was an independent prognostic factor (5-year relapse-free survival: 63.3% vs. 89.8%, p = 0.027; 5-year overall survival: 73.8% vs. 89.9%, p = 0.031, for low vs. high infiltration). This prognostic impact varied according to the tumor PIK3CA mutational status. High ?? T cell infiltration was associated with better survival in patients with PIK3CA wild-type tumors, but the difference was not significant in the subgroup with PIK3CA-mutated tumors. Altogether, these data suggest that high ?? T cell infiltrate is correlated with immune infiltration and might represent a candidate prognostic tool in patients with TNBC. |
Publication | Cancers |
Volume | 13 |
Issue | 4 |
Pages | 765 |
Date | 2021-02-12 |
Journal Abbr | Cancers (Basel) |
Language | eng |
DOI | 10.3390/cancers13040765 |
ISSN | 2072-6694 |
Library Catalog | PubMed |
Extra | PMID: 33673133 PMCID: PMC7918092 |
Tags | ?? T cells, basal-like, BRCA1, first-last-corresponding, last, marque, original, PIK3CA |
Date Added | 2022/07/29 - 15:53:10 |
Date Modified | 2022/08/01 - 16:19:45 |
Notes and Attachments | PubMed entry (Attachment) Texte intégral (Attachment) |